- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Patent holdings for IPC class A61K 47/60
Total number of patents in this class: 3887
10-year publication summary
|
119
|
225
|
351
|
433
|
391
|
434
|
419
|
404
|
384
|
295
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nektar Therapeutics | 437 |
89 |
| Hanmi Pharm. Co., Ltd. | 575 |
71 |
| The Regents of the University of California | 20230 |
61 |
| Bristol-myers Squibb Company | 4848 |
47 |
| Ascendis Pharma A/S | 184 |
44 |
| The Johns Hopkins University | 5739 |
42 |
| Massachusetts Institute of Technology | 10129 |
40 |
| Ascendis Pharma Growth Disorders A/S | 57 |
39 |
| Synthorx, Inc. | 82 |
35 |
| Board of Regents, The University of Texas System | 5917 |
34 |
| Ascendis Pharma Bone Diseases A/S | 48 |
27 |
| Amgen Inc. | 4158 |
26 |
| Quiapeg Pharmaceuticals AB | 45 |
26 |
| Janssen Pharmaceutica N.V. | 3349 |
24 |
| NOK Corporation | 2239 |
23 |
| The Board of Trustees of the Leland Stanford Junior University | 6509 |
22 |
| Northwestern University | 3442 |
22 |
| SeaGen Inc | 594 |
21 |
| Ambrx, Inc. | 181 |
20 |
| Yale University | 2433 |
20 |
| Other owners | 3154 |